Neurotensin vs Cosyntropin
Head-to-head comparison of Neurotensin (Neurotensin) and Cosyntropin (Cosyntropin (ACTH 1-24)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Neurotensin | Cosyntropin |
|---|---|---|
| Category | Pain Management | Pain Management |
| Full Name | Neurotensin | Cosyntropin (ACTH 1-24) |
| Molecular Weight | 1672.94 | 2933.3 Da |
| Half-Life | minutes | ~10 min |
| Amino Acids | 13 | 24 |
| Typical Dose | N/A|N/A | 0.25 mg IV/IM diagnostic dose|off-label headache protocols vary |
| Route | Intranasal/experimental injection | IV|IM |
| Purity | ≥98% | ≥98% |
| Studies Count | 81 | 61 |
| Research Status | Pre-clinical | Clinical research |
Neurotensin Benefits
- ✓antinociceptive signaling
- ✓descending pain modulation
- ✓preclinical pain research
Cosyntropin Benefits
- ✓refractory migraine
- ✓anti-inflammatory signaling
- ✓headache rescue research
Neurotensin Dosing
N/A|N/A
Cosyntropin Dosing
0.25 mg IV/IM|1 mg IV/IM
Neurotensin Side Effects
- ⚠hypotension
- ⚠nausea
- ⚠hypothermia
Cosyntropin Side Effects
- ⚠flushing
- ⚠nausea
Research Overview
Neurotensin
Neurotensin has reproducible analgesic and neuromodulatory effects in preclinical studies, especially in inflammatory and neuropathic pain paradigms. It is not a standard clinical analgesic, but it is a real non-opioid peptide with pain-relevant biology.
Cosyntropin
Cosyntropin is not a standard pain drug, but it appears in headache literature because ACTH analogs can help some patients with difficult migraine attacks. The analgesic rationale is partly tied to steroidogenic and anti-inflammatory effects.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.